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Trichomonas vaginalis infection is highly prevalent worldwide and is associated with urethritis, prostatitis,
and urethral strictures in men. However, the natural history and importance of T. vaginalis in men are poorly
understood, in part because of difficulties in diagnosing infection. Traditional detection methods rely on
culture and wet-mount microscopy, which can be insensitive and time consuming. Urethral swabs are com-
monly used to detect T. vaginalis in men, but discomfort from specimen collection is a barrier to large studies.
One thousand two hundred twenty-five Malawian men attending sexually transmitted disease and dermatology
clinics were enrolled in this cross-sectional study to validate detection by urine-based PCR–enzyme-linked
immunosorbent assay (ELISA) with urine and urethral swab culture as the reference standard. This assay for
detection of amplified T. vaginalis DNA in first-catch urine (<30 ml) performed with a sensitivity of 92.7%, a
specificity of 88.6%, and an adjusted specificity of 95.2% compared to culture of urethral swabs or urine
sediment. For clinical research settings in which urethral swabs are not available and culture is not feasible,
the urine-based PCR-ELISA may be useful for detection of trichomoniasis in men.
In men, trichomoniasis may be associated with urethritis (5,
11) and prostatitis (19). In addition, infection with Trichomo-
nas vaginalis may increase human immunodeficiency virus
(HIV) transmission (2, 4). The estimated prevalence of tricho-
moniasis in men ranges from 0% in asymptomatic men (10, 27)
to 58% in high-risk adolescents (21). Generally, however, the
prevalence of trichomoniasis in men is estimated to be low (7–9).
The reliability of prevalence estimates and an understanding of
the natural history and sequelae of trichomoniasis in men are
affected by difficulties in diagnosing trichomoniasis in men.
Detection of T. vaginalis in men has traditionally relied on
wet-mount microscopy or culture of urine sediment or culture
of urethral scrapings. These methods are highly specific but
lack sensitivity. Collection of urethral material from men with
a swab or loop is uncomfortable and may be a barrier to
participation in research studies. Wet-mount microscopy of
urine sediment requires a large organism burden for a positive
result. Culture is more sensitive than wet preparation, but
results may require 5 or more days of incubation. As a conse-
quence of the time required for culture and the poor sensitivity
of wet-mount microscopy, screening for T. vaginalis infection
in men is infrequent or absent from standard practice at many
clinics. Improved detection and treatment of T. vaginalis in
men should reduce heterosexual transmission of the parasite to
women and may impact HIV transmission.
The introduction of molecular amplification tests to detect
Neisseria gonorrhoeae and Chlamydia trachomatis in urine spec-
imens has facilitated patient care and research studies of in-
fections with these pathogens (1). These tests are more sensi-
tive than culture, and the noninvasive nature of specimen
collection has led to their widespread use. Several PCR assays
have been developed to detect T. vaginalis in urine specimens
from women (5, 12–14, 20, 24). However, detection of T. vagi-
nalis in men by molecular amplification methods has received
less attention. Urine-based PCR assays for men have been
described (18, 22); however, formal validation of the assays has
not been reported.
A useful nucleic acid amplification test for T. vaginalis de-
tection would be applicable for both men and women and use
specimens that could be self-collected noninvasively. We pre-
viously described a urine-based PCR combined with an en-
zyme-linked immunosorbent assay (ELISA) for detection of T.
vaginalis infection in women (5) and herein validate the assay
for use with specimens from men.
MATERIALS AND METHODS
Study population. We conducted a cross-sectional study in the context of a
larger study of the prevalence and management of T. vaginalis infection in men.
Subjects were enrolled between 27 January 2000 and 28 June 2001 from the
sexually transmitted disease (STD) and dermatology outpatient clinics of
Lilongwe Central Hospital, Lilongwe, Malawi. Men 18 years of age and older
were eligible to participate if they provided written informed consent and agreed
to come to follow-up visits for up to 5 weeks after enrollment. Eligible subjects
enrolled through the STD clinic presented with symptoms of urethritis or genital
ulcers; subjects enrolled through the dermatology clinic were asymptomatic with
respect to STDs.
This study was approved by the Committee on the Protection of Human
Subjects of the University of North Carolina at Chapel Hill and the Malawi
Ministry of Health. Consent forms were provided in both English and Chichewa,
the local language.
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Clinical data and specimen collection. Medical history and behavioral data
were collected for all study participants. The standardized questionnaire in-
cluded questions about symptoms, sexual behavior, current medications, and
symptoms of sexual partners. Questionnaires were administered by study staff in
Chichewa.
Specimens were collected during a standardized clinical examination. Obser-
vations, diagnoses, and medications given were recorded on a standardized form.
Blood was collected for HIV and syphilis serology tests. HIV testing was per-
formed with the Capillus HIV-1/HIV-2 rapid test (Cambridge Diagnostics);
positive results were confirmed by enzyme immunoassay (Genetic Systems
HIV-1 peptide EIA; Bio-Rad, Hercules, Calif.). Urethral swabs were collected
for T. vaginalis culture and Gram staining. Urethritis was defined by the presence
of four or more polymorphonuclear cells per high-power field in the Gram-
stained specimen. Infection with N. gonorrhoeae was determined by the presence
of gram-negative intracellular diplococci on the Gram stain. After the physical
examination, subjects were requested to provide 20 to 30 ml of first-void urine in
marked cups.
T. vaginalis culture. Urethral swabs were immediately used to inoculate the TV
InPouch culture system (Biomed, San Jose, Calif.). Urine specimens remained at
room temperature and were processed within 4 h. For urine sediment cultures,
10 ml of first-void urine was centrifuged for 10 min at 1,000  g at room
temperature. The supernatant was aspirated, and 50 l of sediment was used to
inoculate the culture.
Cultures were incubated at 37°C in ambient atmosphere and examined for at
least 1 min per sample by a trained microscopist on days 2 and 5 after inocula-
tion. A recent positive T. vaginalis culture was maintained for comparison.
Positive cultures contained parasites with characteristic morphology and motility.
Motile trichomonads were absent from negative cultures at all readings. The
combination of urine sediment culture and urethral swab culture served as the
reference standard. Subjects with any positive culture were considered positive
by the reference standard.
T. vaginalis PCR-ELISA. Urine samples were processed at Lilongwe Central
Hospital within 4 h of collection with the Amplicor CT Urine Specimen Prep Kit
(Roche Applied Science, Indianapolis, Ind.) or the Amplicor CT/NG Urine
Specimen Prep Kit (Roche Applied Science), in accordance with the manufac-
turer’s instructions. Processed urine samples were frozen at 70°C until ship-
ment in liquid nitrogen to the University of North Carolina for PCR.
A total of 1,225 urine specimens from men was tested with the T. vaginalis
PCR-ELISA. The first 1,028 urine specimens collected for this study were pro-
cessed for PCR with the Amplicor CT Urine Specimen Prep Kit as described in
Materials and Methods. This kit was discontinued by the manufacturer during
the study, and the remaining 197 specimens were processed with the currently
available Amplicor CT/NG Urine Specimen Prep Kit.
Preparations made in Malawi from specimens with the Amplicor CT Urine
Specimen Prep Kit were frozen at 70°C and subsequently extracted with phenol
and chloroform, and DNA was precipitated with 3 M ammonium acetate. Ten
microliters of extracted preparations was used as the template in the PCR.
Specimens processed in Malawi with the Amplicor CT/NG Urine Specimen Prep
Kit did not require extraction. Fifty-microliter volumes of these samples were
used as templates in the PCR. Under these conditions, the two urine preparation
kits used in this study were equivalent.
The T. vaginalis PCR-ELISA was performed as previously described (5).
Briefly, primers TVK3 and TVK7 (digoxigenin labeled) (6) were used to amplify
T. vaginalis DNA specifically. Positive and negative controls were purified T.
vaginalis DNA and sterile water, respectively. PCR products were detected with
the PCR DIG ELISA detection kit (Roche Diagnostic Systems), the biotinylated
TVK probe, and ELISA controls as described previously (5). Specimens and
controls were tested in duplicate by ELISA. Tests were valid if the A405 was 2.0
for the PCR positive control, 1.0 for the ELISA positive control, and 0.2 for
the negative control.
Standard measures were taken to ensure that specimens were not contami-
nated. Separate workspaces were maintained for specimen processing, PCR, and
post-PCR work, and sterile, disposable laboratory supplies were used. The PCR
primers (TVK3 and TVK7) were previously tested against a variety of sexually
transmitted pathogens and other Trichomonas species and found to amplify only
T. vaginalis DNA (6).
Data analysis. Laboratory data were entered into databases created in Mi-
crosoft Excel 2000. Questionnaire and chart information was entered into data-
bases created in EpiInfo version 6.04 (Centers for Disease Control and Preven-
tion, Atlanta, Ga.). All data were double entered by different personnel.
Discrepancies in data entry were resolved by review of chart and laboratory form
information. Data analysis was performed with SAS version 7 (SAS institute,
Cary, N.C.) and STATA version 7 (Stata Corp., College Station, Tex.).
Estimates of the sensitivity and specificity of the test and 95% confidence
intervals (CI) were calculated by standard methods. Nonparametric receiver-
operating characteristic (ROC) curves were constructed by plotting sensitivity
versus 1  specificity at every possible cutoff point along the range of absor-
bances read. The absorbance value corresponding to the upper leftmost point is
the cutoff point at which sensitivity and specificity are jointly maximized.
T. vaginalis culture is insensitive, and culture of specimens from men is gen-
erally less sensitive than that of specimens from women. The imperfect sensitivity
of culture results in biased estimates of the specificity of the new test. We
assessed the impact of reference test bias by adjusting the estimate of specificity
with the formula of Staquet et al. (23) with a high (0.7) and a low (0.5) estimate
of the sensitivity of T. vaginalis culture for men. The high and low estimates were
based on the assumption used previously to validate the T. vaginalis PCR-ELISA
for women (5) and the observation that parasite growth in cultures from men is
less vigorous than in cultures from women (our unpublished observations). We
assumed that the reference standard and PCR tests are independent and that the
specificity of the reference standard is 1.0. Under these conditions, the sensitivity
estimate of the T. vaginalis PCR-ELISA is unbiased (23).
Urine culture, urethral swab culture, and the T. vaginalis PCR-ELISA were
compared to each other by latent-class analysis. This method uses the results of
three or more tests to determine the sensitivity and specificity of each on the
basis of the probability of a positive result from any one test (25, 26). Latent-class
analysis assumes the independence of each test and was performed with software
provided by S. Walter (25, 26).
RESULTS
Patient population. During the study period, 1,361 male
subjects were enrolled, 929 through the STD clinic and 432
through the dermatology clinic. Complete data and specimens
were available for 1,225 study subjects. The ages of study par-
ticipants ranged from 18 to 61 years, with a mean of 26.1 years
(Table 1). Almost half (43.1%) of the study subjects were
married at the time of enrollment. Most (77.7%) reported
current employment. Seventy-eight percent of subjects re-
ported fewer than 2 sexual partners in the previous 4 weeks,
with a range of 0 to 30 partners.
Common signs and symptoms in the STD clinic were ure-
thral discharge, genital ulcer disease, dysuria, and urethritis
(Table 2). HIV was diagnosed in 46.7% of STD clinic subjects
(n  434) and 27.6% of dermatology clinic subjects (n  119).
The 136 subjects (10% of the study population) for whom
complete data and specimens were not available were similar









Total (mean) .......................................................................18–61 (26.1)
Married....................................................................................528 (43.1)
Current employment..............................................................952 (77.7)




3 or more............................................................................. 64 (5.2)
a Total, 1,225.
b Age ranges are given in years.
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to the rest of the study population in demographics and clinical
characteristics (data not shown).
T. vaginalis was detected by culture of urethral swab or urine
sediment in 9.0% (n  84) of the study subjects enrolled
through the STD clinic and 3.2% (n  14) of the subjects from
the dermatology clinic. The prevalence of culture-proven T.
vaginalis among HIV-positive subjects was 6.7% (n  53), and
among HIV-negative subjects, it was 8.1% (n  45). Tricho-
moniasis was more common among men with urethritis (9.6%;
n  57) than among men without urethritis (5.4%; n  41).
Performance of the T. vaginalis PCR-ELISA. To determine
an appropriate absorbance cutoff value for the T. vaginalis
PCR-ELISA of urine from men, a ROC curve was constructed
as described in Materials and Methods (Fig. 1). The area under
the unadjusted curve was 0.891 (standard error  0.025), in-
dicating a high degree of overall accuracy of the test. At an
absorbance cutoff of 2.0, the urine PCR performed with 88.9%
sensitivity (95% CI, 79.2 to 94.4) and an unadjusted specificity
of 88.6% (95% CI, 86.8 to 90.4) compared to culture. Raising
the A405 cutoff to 3.0 reduced the sensitivity to 86.3% (95% CI,
76.3 to 92.6) and increased the specificity to 90.3% (95% CI,
88.4 to 91.9). To maximize sensitivity, we chose an absorbance
cutoff value of 2.0.
T. vaginalis culture is recognized as imperfectly sensitive and
virtually 100% specific. With culture as the reference standard,
the specificity of the T. vaginalis PCR-ELISA will be underes-
timated. To compensate for this reference test bias, we ad-
justed the specificity estimate algebraically by the method of
Staquet et al. (23) with a high (70%) and a low (50%) estimate
for the sensitivity of T. vaginalis culture for men. The effects of
the specificity adjustments on the ROC curve are shown in Fig.
1. At an absorbance cutoff of 2.0, the adjusted specificities of
the urine PCR were 91.0 and 94.5% for the high and low
culture estimates, respectively.
The ROC curves display an early deviation from the vertical
axis, indicating that the specificity of the T. vaginalis PCR-
ELISA falls off rapidly. This portion of the curve corresponds
to very high absorbance cutoff values. Such a shape is consis-
tent with the possible misclassification of truly positive speci-
mens as false positives. To examine the performance of the T.
vaginalis PCR-ELISA further, we graphed the results for each
specimen according to its absorbance from the ELISA and the
corresponding result of the combined reference standard (Fig.
2). The histograms had two distinct peaks, one at absorbances
of 0.5 and one at absorbances of 3.0. Most of the culture-
negative specimens had correspondingly low absorbances, and
the majority of culture-positive specimens had very high ab-
sorbances. However, 64% of the specimens with absorbances
of 2.0 were negative for T. vaginalis by culture. There were
few specimens with absorbances between the lower peak and
the cutoff point of 2.0, i.e., only 3.4% (n  40) of the culture-
negative specimens and 1.2% (n  1) of the culture-positive
specimens. The two distinct peaks with few observations lo-
cated between them suggest that many specimens with absor-
bances above the cutoff point may represent infections with T.
vaginalis despite negative culture results.
Effect of specimen processing. Because the urine prepara-
tion method changed during the course of the study, we as-
sessed the performance of the assay with each method sepa-
rately. The sensitivity of the assay with specimens processed
with the discontinued kit was slightly higher (89.0%), and the
adjusted specificity was slightly lower (94.3%), than that of the
assay with specimens processed with the currently available kit
(sensitivity, 85.7%; adjusted specificity, 96.2%).
Effects of clinical factors and specimen volume. We com-
pared the performance of the T. vaginalis PCR-ELISA with
samples from subjects with different clinical characteristics.
The test performed with comparable sensitivity and specificity
for subjects with or without urethritis (four or more polymor-
FIG. 1. ROC analysis of PCR-ELISA for detection of T. vaginalis
in men’s urine. ROC curves were plotted for the T. vaginalis PCR-
ELISA, and specificity was adjusted by assigning the reference stan-
dard sensitivities of 50 and 70%.









Complaint of urethral discharge 515 (37.9) 515 (55.5)
Genital ulcer diseasea 534 (39.3) 533 (57.4)
Dysuria 623 (45.8) 591 (63.6)
Observed urethral discharge 530 (38.9) 530 (57.1)
Urethritisb 593 (43.6) 568 (61.1)
STDsc
T. vaginalis infection 98 (7.2) 84 (9.1)
N. gonorrhoeae infection 407 (30.0) 406 (43.8)
HIV infection 553 (40.6) 434 (46.7)
a As observed by a clinician.
b Four or more polymorphonuclear cells per high-power field.
c T. vaginalis infection was diagnosed by culture, N. gonorrhoeae infection was
diagnosed by Gram staining of urethral material, and HIV infection was diag-
nosed by Capillus HIV-1/HIV-2 rapid test and confirmed by enzyme immuno-
assay.
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phonuclear cells per high-power field), urethral discharge, gen-
ital ulcers, or concomitant STDs (Table 3).
The volume of urine collected was predicted to affect the
performance of the T. vaginalis PCR-ELISA. With larger spec-
imen volumes, the expected concentration of organisms in
urine is lower. Although subjects were instructed to collect the
first 20 to 30 ml of first-void urine, many specimens exceeded
these limits. Urine volumes ranged from 2 to 80 (mean, 32.7)
ml. The T. vaginalis PCR-ELISA was slightly, but not signifi-
cantly, more sensitive, and its adjusted specificity was higher,
with specimens of 30 ml or less than with specimens of larger
volumes (Table 3).
DISCUSSION
This study validates the use of PCR-based detection of T.
vaginalis in urine samples from men. We observed an overall
sensitivity of 88.8% and an adjusted specificity of 94.5% com-
pared to culture of urine sediment and urethral swabs. In
specimens that met the volume requirements, the test per-
formed with 92.7% sensitivity and 95.2% adjusted specificity.
We previously reported a validation study of a PCR assay for
detection of T. vaginalis in urethral swabs from men with
81.6% sensitivity and 97.9% specificity (4). The current T.
vaginalis PCR-ELISA had a higher sensitivity and a lower
specificity than the previously validated PCR method. The two
assays used the same primers and similar PCR methods. How-
ever, the previously validated test used gel electrophoresis to
detect amplified PCR products. ELISA detection of amplified
sequences is more sensitive than gel electrophoresis (5) and
may explain the greater sensitivity of the assay described here.
The higher sensitivity would also increase the number of in-
fections missed by culture alone, thus increasing the false-
positive fraction and lowering the observed specificity.
The choice of reference test is crucial for the evaluation of
any new testing method. Culture is currently considered the
best method by which to diagnose trichomoniasis. We chose to
combine the results of two acceptable culture specimens. Ure-
thral swab specimens are reported to be the most sensitive
single specimens for culture of T. vaginalis in men, followed by
urine sediment (7). Men can harbor T. vaginalis at multiple
sites in the reproductive tract, and frequently organisms may
be found in one specimen but not in another from the same
individual (reference 7 and our unpublished observations). Be-
cause we hypothesized that PCR would be more sensitive than
culture, we designed the reference test to maximize its sensi-
tivity. In this study, the sensitivity of the reference standard was
increased by 51% over that of urethral swab culture alone by
inclusion of urine sediment culture.
Although urethral swabs are frequently considered the most
sensitive specimens for T. vaginalis detection in men, addition
of urine testing to increase sensitivity has been suggested (9). If
we had also tested urethral swab specimens with the T. vagi-
nalis PCR-ELISA, the sensitivity and specificity of the assay
might have improved. Testing of either urine or urethral swabs,
but not both, would result in some missed cases of disease, and
the two types of specimen may result in equal sensitivity (S. C.
Kaydos, M. M. Hobbs, M. A. Price, et al., Abstr. Int. Congr.
Sex. Transm. Infect., p. 38, 2001). However, collection of ure-
FIG. 2. Distribution of ELISA absorbance values for T. vaginalis
PCR assay of men’s urine. Histograms show data for men who were
positive (top) or negative (bottom) by the reference standard of urine
sediment culture and urethral swab culture.
TABLE 3. Performance of T. vaginalis PCR-ELISA with










Present 521 87.2 (73.6–94.7) 89.0 (85.8–91.6) 97.5
Absent 701 90.9 (74.5–97.6) 88.5 (85.7–90.7) 92.7
HIV
Positive 496 84.6 (68.8–93.6) 86.9 (83.3–89.8) 93.5
Negative 711 92.7 (79.0–98.1) 89.7 (87.1–91.8) 95.1
N. gonorrhoeaeb
Positive 364 85.0 (61.1–96.0) 89.5 (85.7–92.5) 94.1
Negative 858 90.0 (78.8–95.9) 88.3 (85.9–90.4) 94.7
Dysuria
Present 554 86.8 (71.1–95.1) 89.7 (86.7–92.1) 95.8
Absent 671 90.5 (76.5–96.9) 87.8 (84.9–90.2) 93.4
Urethral dischargec
Present 464 87.9 (70.9–96.0) 90.3 (87.0–92.8) 96.7
Absent 761 89.4 (76.1–96.0) 87.7 (85.0–90.0) 93.1
Urine volume
30 ml 646 84.2 (68.1–93.4) 89.0 (86.2–91.3) 93.7
30 ml 559 92.7 (79.0–98.1) 88.2 (85.1–90.8) 95.2
a Four or more polymorphonuclear cells per high-power field.
b Infection based on presence of gram-negative intracellular diplococci on
Gram staining.
c As observed by a clinician on physical examination.
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thral swabs is an invasive procedure, is uncomfortable for pa-
tients, requires a clinic visit, and is impractical for large, pop-
ulation-based studies. The addition of a urine-based screening
test for T. vaginalis would complement routinely used similar
tests for gonorrhea and chlamydial infection. In addition, the
T. vaginalis PCR-ELISA has been validated for testing of sam-
ples from women (5), and uniform collection and processing
procedures for men and women should increase the utility of
the test.
Discrepant analysis has been used in other validation studies
of PCR assays for detection of T. vaginalis (14, 20). To avoid
the sensitivity and specificity biases that can occur as a result of
discrepant analysis (3, 15–17), we used an algebraic method to
decrease reference test bias (23). Part of the adjustment for
specificity requires assignment of the sensitivity of the refer-
ence standard, and it is important to estimate this value accu-
rately. We compared test performance by assigning a value of
50 or 70% sensitivity to the reference test. In our previous
study with samples from women, the sensitivity of a combined
reference standard using wet-mount microscopy and culture of
vaginal fluids was estimated to be 70% (5). The assumption
that the combination of urethral swab culture and urine sedi-
ment culture for men is as sensitive as vaginal swab culture and
wet-mount microscopy for women was explored for compari-
son. However, several observations suggest that the reference
standard may be even less sensitive for men than for women.
The T. vaginalis organism burden appears to be lower in men
than in women, and cultures do not thrive as well as those of
clinical isolates from women (our unpublished observations).
In our experience, within 1 or 2 days of collection, the great
majority of positive cultures from females teem with
trichomonads whereas cultures from men frequently have only
a few trichomonads and the numbers often do not increase
over the culture period (unpublished observations). Thus, the
assumption of 50% sensitivity of the reference standard in this
study is reasonable and should not result in an overestimate of
the specificity of the T. vaginalis PCR-ELISA.
Despite algebraic adjustment, the performance of the T.
vaginalis PCR-ELISA may still be affected by reference test
bias. Reference test-positive specimens generally had high ab-
sorbances in the ELISA (Fig. 2). There are two peaks of
reference test-negative specimens on the histogram, one be-
tween 0.000 and 0.500 and one between 3.000 and 3.600. Rais-
ing the cutoff point for the ELISA would have increased the
specificity of the test only slightly. The ROC curve with early
deviation from the vertical axis and the shape of the histogram
(Fig. 2), two peaks with very few specimens between them,
suggest that many of the specimens in the second peak repre-
sent trichomoniasis cases that were not detected by the refer-
ence standard test. This result is unavoidable when comparing
a highly sensitive detection method to a less sensitive reference
standard.
The urine-based T. vaginalis PCR-ELISA was designed for
use in large-scale studies of STDs involving men and women
and was therefore simplified where possible. In the present
study, specimens were processed on the day of collection.
However, the previous study with samples from women dem-
onstrated similar sensitivity and specificity for urine specimens
that were stored at 4°C for up to 4 days (5). The T. vaginalis
PCR-ELISA compared favorably to urine sediment culture
and urethral swab culture, both of which are prohibitively time
consuming and logistically difficult for large studies. The use of
a commercially available kit to process urine facilitates work
that must be performed in the field or in modestly equipped
laboratories. This method should facilitate the detection of
trichomoniasis, which may increase our knowledge of the ep-
idemiology and natural history of T. vaginalis infection in men
and their female partners.
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